ArticleBlood cancer journal2021

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia.

Ya-Zhen Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.